No Image Available

PF ablation catheters

Sphere-360™ pulsed field ablation catheter

<p>Sphere-360™ pulsed field ablation (PFA) single shot catheter delivers mapping and rotation free ablation for paroxysmal atrial fibrillation treatment.</p>


Single shot PFA catheter designed for your workflow

View the Sphere-360™ pulsed field ablation catheter tip with numbered callouts.

 

  1. Conformable lattice expandable to 34 mm
  2. Six bipolar electrode pairs enable mapping and stimulation
  3. Over-the-wire for enhanced stability
  4. Electromagnetic sensors for tracking and shape visualization
  5. Compatible with a 10 Fr deflectable sheath


Full circle ablation. No rotation.

Designed for every EP, the Sphere‑360™ PFA system delivers safe, efficient, and durable PVI through a simple ZeroTurn™ workflow1. It achieves complete isolation in only four applications with no catheter rotation needed.




The adjustable lattice seamlessly expands from linear to disc shape up to 34 mm, adapting to a wide range of PV anatomies.1


View the Sphere-360™ pulsed field ablation system animation creating circumferential ablation lesions with zero rotation.


Deliver circumferential Span360™ ablation lesions2 with zero rotation.



See the conformability of the Sphere-360™ pulsed field ablation catheter tip.


The catheter provides easy maneuverability with a conformable,3 atraumatic lattice.



360 integration. Zero exchange.

The Sphere‑360™ PFA catheter is exclusively integrated with the Affera™ mapping and ablation system. Its all‑in‑one design delivers navigation, mapping, and ablation through a single catheter.


Get access to refined insights with Prism-2 mapping software and real-time tissue proximity feedback.


Illustration showing the real-time local impedance of the Sphere-360™ pulsed field ablation (PFA) catheter.

Real-time local impedance

This is an image showing the lesion tags and location of the Sphere-360™ pulsed field ablation (PFA) catheter shown on the Affera™ mapping and ablation system.

Lesion tags and location

This is an image showing the low- to zero-fluoro workflow on the Sphere-360™ pulsed field ablation (PFA) catheter shown on the Affera™ mapping and ablation system.

Low- to zero-fluoro

This is an image showing the clear view of the coronary sinus catheter and guidewire of the Sphere-360™ pulsed field ablation (PFA) catheter shown on the Affera™ mapping and ablation system.

Visualize coronary sinus catheter




The Sphere-360™ mapping and ablation catheter is compatible with the zero exchange and single transseptal puncture workflows. These workflows are enabled by the FlexCath Contour™ steerable sheath and FlexCath Cross™ transeptal solution.

This is an image showing the FlexCath Contour™ steerable sheath 10 Fr connected to the FlexCath Cross™ transseptal solution system.


Consistent outcomes. Full confidence.

The Sphere-360™ catheter delivers predictable workflows and lasting results across centers — with reliability and confidence in your procedure.

The Sphere-360™ CE Mark study was a prospective, single-arm, multicenter trial. It was designed to evaluate the safety, effectiveness, and lesion durability of the Sphere-360™ catheter. The catheter was used for the treatment of symptomatic, drug-refractory paroxysmal atrial fibrillation (PAF) in 100 patients.¹

  • 98% per PV durability (75-day remap)
  • 88% efficacy (1-year follow-up)
  • 0 primary safety events
  • 22 minute LA dwell time§
  • < 12 min PV transpired time§
  • < 7 min fluoro time§,◊




This is an icon of open quotes.

Sphere-360™ offers a new generation catheter for a single shot ablation. The high conformability of the catheter performs very well. Because it is a compliant sphere, it can adapt to the tissue ... It can be seamlessly adapted to different shapes, because the anatomy of the pulmonary vein is highly individualized.”

– Petr Peichl, MD, PhD, on his experience with the Sphere-360™ PFA catheter for AF treatment

This is a portrait of Dr. Petr Peichl, MD, PhD.


Ordering information

Item number Description 
AFR-00012 Sphere-360™ PFA catheter

 

† Fifty patients treated with the PULSE3 optimized and most recent waveform configuration, 40 of which completed the optional remapping procedure.

‡ See manuscript for all adverse event incidence.

§ Total cohort (N = 100).

Four patients done with 0 fluoro; 26 patients with less than or equal to three minutes of fluoro.

  1. Reddy VY, Peichl P, Kautzner J, et al. One-year outcomes of a conformable single-shot pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation. Heart Rhythm. 2025;22(10): 2551–2561. doi.org/10.1016/j.hrthm.2025.04.031.
  2. Catheter 28-day GLP study. December 2025. Medtronic data on file.
  3. Catheter tip performance. December 2025. Medtronic data on file.